{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:33:07Z","timestamp":1774503187785,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-026-00790-w","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:38:13Z","timestamp":1774496293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The anti-diabetic drug acarbose modulates the nucleation dependent amyloid fibrillation of wild-type \u03b1-synuclein"],"prefix":"10.1007","volume":"40","author":[{"given":"Almas","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Admane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"1","key":"790_CR1","doi-asserted-by":"publisher","first-page":"e10367","DOI":"10.1002\/btm2.10367","volume":"8","author":"P Chopade","year":"2023","unstructured":"Chopade P, Chopade N, Zhao Z et al (2023) Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioeng Transl Med 8(1):e10367","journal-title":"Bioeng Transl Med"},{"key":"790_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Van Den Bosch L et al (2023) Hallmarks of neurodegenerative diseases. Cell 186:693\u2013714","journal-title":"Cell"},{"key":"790_CR3","doi-asserted-by":"publisher","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. https:\/\/doi.org\/10.1136\/bmj-2024-080952","DOI":"10.1136\/bmj-2024-080952"},{"key":"790_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162717","author":"C Hoenen","year":"2016","unstructured":"Hoenen C, Gustin A, Birck C et al (2016) Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: Stronger effects of the a53t mutant. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0162717","journal-title":"PLoS ONE"},{"key":"790_CR5","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF (2016) Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 22:S119\u2013S122. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.004","journal-title":"Parkinsonism Relat Disord"},{"key":"790_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4613-0759-4_2","volume-title":"Progress in Parkinson Research","author":"LS Forno","year":"1988","unstructured":"Forno LS (1988) The Neuropathology Of Parkinson\u2019S Disease. Progress in Parkinson Research. Springer US, Boston, MA, pp 11\u201321"},{"key":"790_CR7","unstructured":"Lewy FH (1912) Paralysis agitans. I. Pathologische anatomie. Handbuch der neurologie 3:920\u2013958"},{"key":"790_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the \u03b1-Synuclein gene identified in families with Parkinson\u2019s disease. Sci (1979) 276:2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Sci (1979)"},{"issue":"4","key":"790_CR9","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152(4):879","journal-title":"Am J Pathol"},{"key":"790_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492\u2013501. https:\/\/doi.org\/10.1038\/35081564","journal-title":"Nat Rev Neurosci"},{"key":"790_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2012","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2012) The many faces of \u03b1-synuclein: From structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348","journal-title":"Nat Rev Neurosci"},{"key":"790_CR12","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of \u03b1-Synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443\u20139449. https:\/\/doi.org\/10.1074\/jbc.273.16.9443","journal-title":"J Biol Chem"},{"key":"790_CR13","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IVJ, Trojanowski JQ, Lee VMY (2001) A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of \u03b1-Synuclein Is Essential for Filament Assembly. J Biol Chem 276:2380\u20132386. https:\/\/doi.org\/10.1074\/jbc.M008919200","journal-title":"J Biol Chem"},{"key":"790_CR14","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1021\/bi900539p","volume":"48","author":"EA Waxman","year":"2009","unstructured":"Waxman EA, Mazzulli JR, Giasson BI (2009) Characterization of hydrophobic residue requirements for \u03b1-synuclein fibrillization. Biochemistry 48:9427\u20139436. https:\/\/doi.org\/10.1021\/bi900539p","journal-title":"Biochemistry"},{"key":"790_CR15","doi-asserted-by":"crossref","unstructured":"Oueslati A, Fournier M, Lashuel HA (2010) Role of post-translational modifications in modulating the structure, function and toxicity of \u03b1-synuclein. Implications for Parkinson\u2019s disease pathogenesis and therapies. In: Progress in Brain Research. Elsevier B.V., pp 115\u2013145","DOI":"10.1016\/S0079-6123(10)83007-9"},{"key":"790_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1515\/revneuro-2012-0071","volume":"24","author":"H Sato","year":"2013","unstructured":"Sato H, Kato T, Arawaka S (2013) The role of Ser129 phosphorylation of \u03b1-synuclein in neurodegeneration of Parkinson \u2019 s disease: A review of in vivo models. Rev Neurosci 24:115\u2013123. https:\/\/doi.org\/10.1515\/revneuro-2012-0071","journal-title":"Rev Neurosci"},{"key":"790_CR17","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T et al (2010) \u03b1-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro. Sci (1979) 329:1663\u20131667. https:\/\/doi.org\/10.1126\/science.1195227","journal-title":"Sci (1979)"},{"key":"790_CR18","doi-asserted-by":"publisher","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","volume":"274","author":"PH Jensen","year":"1999","unstructured":"Jensen PH, Hager H, Nielsen MS et al (1999) \u03b1-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 274:25481\u201325489. https:\/\/doi.org\/10.1074\/jbc.274.36.25481","journal-title":"J Biol Chem"},{"key":"790_CR19","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1021\/ja209829m","volume":"134","author":"I Horvath","year":"2012","unstructured":"Horvath I, Weise CF, Andersson EK et al (2012) Mechanisms of Protein Oligomerization: Inhibitor of Functional Amyloids Templates \u03b1-Synuclein Fibrillation. J Am Chem Soc 134:3439\u20133444. https:\/\/doi.org\/10.1021\/ja209829m","journal-title":"J Am Chem Soc"},{"key":"790_CR20","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway KA, Harper JD, Lansbury PT (2000) Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid. Biochemistry 39:2552\u20132563. https:\/\/doi.org\/10.1021\/bi991447r","journal-title":"Biochemistry"},{"key":"790_CR21","doi-asserted-by":"publisher","first-page":"e36402","DOI":"10.7554\/eLife.36402.001","volume":"7","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R, Britschgi M, Stahlberg H (2018) Cryo-EM structure of alpha-synuclein fibrils. elife 7:e36402. https:\/\/doi.org\/10.7554\/eLife.36402.001","journal-title":"elife"},{"key":"790_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0014-5793(02)02883-1","volume":"522","author":"VN Uversky","year":"2002","unstructured":"Uversky VN, Fink AL (2002) Amino acid determinants of \u03b1-synuclein aggregation: putting together pieces of the puzzle. FEBS Lett 522:9\u201313. https:\/\/doi.org\/10.1016\/S0014-5793(02)02883-1","journal-title":"FEBS Lett"},{"key":"790_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature15368","volume":"525","author":"JA Rodriguez","year":"2015","unstructured":"Rodriguez JA, Ivanova MI, Sawaya MR et al (2015) Structure of the toxic core of \u03b1-synuclein from invisible crystals. Nature 525:486\u2013490. https:\/\/doi.org\/10.1038\/nature15368","journal-title":"Nature"},{"key":"790_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00540","author":"EN Anderson","year":"2020","unstructured":"Anderson EN, Hirpa D, Zheng KH et al (2020) The non-amyloidal Component Region of \u03b1-Synuclein Is important for \u03b1-Synuclein transport within axons. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2019.00540","journal-title":"Front Cell Neurosci"},{"key":"790_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today 21:802\u2013818. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.013","journal-title":"Drug Discov Today"},{"key":"790_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/bph.15508","volume":"179","author":"C H\u00f6lscher","year":"2022","unstructured":"H\u00f6lscher C (2022) Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders. Br J Pharmacol 179:695\u2013714. https:\/\/doi.org\/10.1111\/bph.15508","journal-title":"Br J Pharmacol"},{"key":"790_CR27","doi-asserted-by":"publisher","first-page":"pyw047","DOI":"10.1093\/ijnp\/pyw047","volume":"19","author":"M Lu","year":"2016","unstructured":"Lu M, Su C, Qiao C et al (2016) Metformin prevents dopaminergic neuron death in mptp\/p-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance. Int J Neuropsychopharmacol 19:pyw047. https:\/\/doi.org\/10.1093\/ijnp\/pyw047","journal-title":"Int J Neuropsychopharmacol"},{"key":"790_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.838173","author":"M-R Du","year":"2022","unstructured":"Du M-R, Gao Q-Y, Liu C-L et al (2022) Exploring the pharmacological potential of metformin for neurodegenerative diseases. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.838173","journal-title":"Front Aging Neurosci"},{"key":"790_CR29","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","volume":"390","author":"D Athauda","year":"2017","unstructured":"Athauda D, Maclagan K, Skene SS et al (2017) Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet 390:1664\u20131675. https:\/\/doi.org\/10.1016\/S0140-6736(17)31585-4","journal-title":"Lancet"},{"key":"790_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JPD-181503","volume":"9","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhang L, Li L, H\u00f6lscher C (2019) Semaglutide is Neuroprotective and Reduces \u03b1-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson\u2019s Disease. J Parkinsons Dis 9:157\u2013171. https:\/\/doi.org\/10.3233\/JPD-181503","journal-title":"J Parkinsons Dis"},{"key":"790_CR31","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1021\/acschemneuro.4c00729","volume":"16","author":"P Delvadia","year":"2025","unstructured":"Delvadia P, Dhote V, Mandloi AS et al (2025) Dual GLP-1 and GIP agonist tirzepatide exerted neuroprotective action in a Parkinson\u2019s disease Rat Model. ACS Chem Neurosci 16:818\u2013825. https:\/\/doi.org\/10.1021\/acschemneuro.4c00729","journal-title":"ACS Chem Neurosci"},{"key":"790_CR32","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1038\/s41467-022-31232-4","volume":"13","author":"T Tsunoda","year":"2022","unstructured":"Tsunoda T, Samadi A, Burade S, Mahmud T (2022) Complete biosynthetic pathway to the antidiabetic drug acarbose. Nat Commun 13:3455. https:\/\/doi.org\/10.1038\/s41467-022-31232-4","journal-title":"Nat Commun"},{"key":"790_CR33","doi-asserted-by":"publisher","first-page":"e000327","DOI":"10.1136\/openhrt-2015-000327","volume":"2","author":"JJ DiNicolantonio","year":"2015","unstructured":"DiNicolantonio JJ, Bhutani J, O\u2019Keefe JH (2015) Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open Heart 2:e000327. https:\/\/doi.org\/10.1136\/openhrt-2015-000327","journal-title":"Open Heart"},{"key":"790_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1475-2840-13-81","volume":"13","author":"E Standl","year":"2014","unstructured":"Standl E, Theodorakis MJ, Erbach M et al (2014) On the potential of acarbose to reduce cardiovascular disease. Cardiovasc Diabetol 13:81. https:\/\/doi.org\/10.1186\/1475-2840-13-81","journal-title":"Cardiovasc Diabetol"},{"key":"790_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13205-022-03130-5","volume":"12","author":"J Das","year":"2022","unstructured":"Das J, Mahammad FS, Krishnamurthy RG (2022) An integrated chemo-informatics and in vitro experimental approach repurposes acarbose as a post-ischemic neuro-protectant. 3 Biotech 12:71. https:\/\/doi.org\/10.1007\/s13205-022-03130-5","journal-title":"3 Biotech"},{"key":"790_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.14336\/AD.2019.0621","volume":"11","author":"C-H Tseng","year":"2020","unstructured":"Tseng C-H (2020) Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone. Aging Dis 11:658. https:\/\/doi.org\/10.14336\/AD.2019.0621","journal-title":"Aging Dis"},{"key":"790_CR37","doi-asserted-by":"publisher","unstructured":"Meena VK, Kumar V, Karalia S (2021) Inhibitory effect of naturally occurring Ocimum sanctum extract on \u03b1-Synuclein aggregation in aqueous solution. J Mol Liq 336. https:\/\/doi.org\/10.1016\/j.molliq.2021.116176","DOI":"10.1016\/j.molliq.2021.116176"},{"key":"790_CR38","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.bpj.2019.09.046","volume":"117","author":"I Jahan","year":"2019","unstructured":"Jahan I, Nayeem SM (2019) Effect of osmolytes on conformational behavior of intrinsically disordered protein \u03b1-Synuclein. Biophys J 117:1922\u20131934. https:\/\/doi.org\/10.1016\/j.bpj.2019.09.046","journal-title":"Biophys J"},{"key":"790_CR39","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1080\/07391102.2020.1728384","volume":"39","author":"P Borah","year":"2021","unstructured":"Borah P, Sanjeev A, Mattaparthi VSK (2021) Computational investigation on the effect of Oleuropein aglycone on the \u03b1-synuclein aggregation. J Biomol Struct Dyn 39:1259\u20131270. https:\/\/doi.org\/10.1080\/07391102.2020.1728384","journal-title":"J Biomol Struct Dyn"},{"key":"790_CR40","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.4c01839","author":"F Huang","year":"2024","unstructured":"Huang F, Yan J, Xu H et al (2024) Exploring the impact of physiological C-Terminal truncation on \u03b1-synuclein conformations to unveil mechanisms regulating pathological aggregation. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.4c01839","journal-title":"J Chem Inf Model"},{"key":"790_CR41","doi-asserted-by":"publisher","first-page":"7068","DOI":"10.1021\/acs.jpcb.4c01743","volume":"128","author":"G Chakraborty","year":"2024","unstructured":"Chakraborty G, Patra N (2024) Elucidating the molecular basis of 14-3-3 Interaction with \u03b1-Synuclein: insights from molecular dynamics simulations and the design of a novel protein-protein interaction inhibitor. J Phys Chem B 128:7068\u20137085. https:\/\/doi.org\/10.1021\/acs.jpcb.4c01743","journal-title":"J Phys Chem B"},{"key":"790_CR42","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1021\/acschemneuro.1c00379","volume":"12","author":"B Saffari","year":"2021","unstructured":"Saffari B, Amininasab M (2021) Crocin inhibits the fibrillation of human \u03b1-synuclein and disassembles mature fibrils: experimental findings and mechanistic insights from molecular dynamics simulation. ACS Chem Neurosci 12:4037\u20134057. https:\/\/doi.org\/10.1021\/acschemneuro.1c00379","journal-title":"ACS Chem Neurosci"},{"key":"790_CR43","volume-title":"5.0, Schr\u00f6dinger","author":"V Glide","year":"2009","unstructured":"Glide V (2009) 5.0, Schr\u00f6dinger. LLC, New York, NY. User manual"},{"key":"790_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"790_CR45","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"790_CR46","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"790_CR47","unstructured":"Schrodinger LLC (2015) The PyMOL Molecular Graphics System, Version 1.8"},{"key":"790_CR48","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u","journal-title":"J Chem Inf Model"},{"key":"790_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R et al (2015) Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"790_CR50","doi-asserted-by":"publisher","first-page":"141076","DOI":"10.1016\/j.bbapap.2025.141076","volume":"1873","author":"A Akhtar","year":"2025","unstructured":"Akhtar A, Singh P, Admane N, Grover A (2025) Parishin C modulates the amyloid transformation of alpha-synuclein protein by apparently interacting with the NAC domain. Biochimica et Biophysica Acta (BBA) -. Proteins Proteom 1873:141076. https:\/\/doi.org\/10.1016\/j.bbapap.2025.141076","journal-title":"Proteins Proteom"},{"key":"790_CR51","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE et al (2016) PubChem substance and compound databases. Nucleic Acids Res 44:D1202\u2013D1213. https:\/\/doi.org\/10.1093\/nar\/gkv951","journal-title":"Nucleic Acids Res"},{"key":"790_CR52","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Sch\u00fcttelkopf","year":"2004","unstructured":"Sch\u00fcttelkopf AW, van Aalten DMF (2004) PRODRG: a tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Crystallogr D Biol Crystallogr 60:1355\u20131363. https:\/\/doi.org\/10.1107\/S0907444904011679","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"790_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2021.108010","author":"M Sahihi","year":"2021","unstructured":"Sahihi M, Gaci F, Navizet I (2021) Identification of new alpha-synuclein fibrillogenesis inhibitor using in silico structure-based virtual screening. J Mol Graph Model. https:\/\/doi.org\/10.1016\/j.jmgm.2021.108010","journal-title":"J Mol Graph Model"},{"key":"790_CR54","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/07391102.2016.1276478","volume":"36","author":"S Kundu","year":"2018","unstructured":"Kundu S (2018) Effects of different force fields on the structural character of \u03b1 synuclein \u03b2-hairpin peptide (35\u201356) in aqueous environment. J Biomol Struct Dyn 36:302\u2013317. https:\/\/doi.org\/10.1080\/07391102.2016.1276478","journal-title":"J Biomol Struct Dyn"},{"key":"790_CR55","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.32604\/biocell.2022.021224","volume":"46","author":"R Ali","year":"2022","unstructured":"Ali R, Alam A, Rajput SK, Ahmad R (2022) Pharmacotherapeutics and molecular docking studies of alpha-synuclein modulators as promising therapeutics for Parkinson\u2019s disease. Biocell 46:2681\u20132694. https:\/\/doi.org\/10.32604\/biocell.2022.021224","journal-title":"Biocell"},{"key":"790_CR56","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen HJC, Postma JPM, Van Gunsteren WF et al (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684\u20133690. https:\/\/doi.org\/10.1063\/1.448118","journal-title":"J Chem Phys"},{"issue":"3","key":"790_CR57","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover WG (1985) Canonical dynamics: equilibrium phase-space distributions. Phys Rev A 31(3):1695","journal-title":"Phys Rev A"},{"key":"790_CR58","doi-asserted-by":"crossref","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. John Wiley & Sons, Inc","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H"},{"key":"790_CR59","doi-asserted-by":"crossref","unstructured":"Miyamoto S, Kollman (1992) PASETTLE an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13(8): 952\u2013962","DOI":"10.1002\/jcc.540130805"},{"key":"790_CR60","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1039\/b716554d","volume":"10","author":"A Patriksson","year":"2008","unstructured":"Patriksson A, Van Der Spoel D (2008) A temperature predictor for parallel tempering simulations. Phys Chem Chem Phys 10:2073\u20132077. https:\/\/doi.org\/10.1039\/b716554d","journal-title":"Phys Chem Chem Phys"},{"key":"790_CR61","first-page":"51","volume":"445","author":"W McKinney","year":"2010","unstructured":"McKinney Wothers (2010) Data structures for statistical computing in Python. scipy 445:51\u201356","journal-title":"scipy"},{"key":"790_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: a 2D graphics environment. Comput Sci Eng 9:90\u201395. https:\/\/doi.org\/10.1109\/MCSE.2007.55","journal-title":"Comput Sci Eng"},{"key":"790_CR63","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","volume":"109","author":"RT McGibbon","year":"2015","unstructured":"McGibbon RT, Beauchamp KA, Harrigan MP et al (2015) MDTraj: a modern open library for the analysis of molecular dynamics trajectories. Biophys J 109:1528\u20131532. https:\/\/doi.org\/10.1016\/j.bpj.2015.08.015","journal-title":"Biophys J"},{"key":"790_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2024.107379","author":"A Akhtar","year":"2024","unstructured":"Akhtar A, Singh P, Admane N, Grover A (2024) Salvianolic acid B prevents the amyloid transformation of A53T mutant of \u03b1-synuclein. Biophys Chem 107379. https:\/\/doi.org\/10.1016\/j.bpc.2024.107379","journal-title":"Biophys Chem 107379"},{"key":"790_CR65","doi-asserted-by":"publisher","first-page":"25929","DOI":"10.1039\/D0RA04949B","volume":"10","author":"A Kumari","year":"2020","unstructured":"Kumari A, Sharma R, Shrivastava N et al (2020) Bleomycin modulates amyloid aggregation in \u03b2-amyloid and hIAPP. RSC Adv 10:25929\u201325946. https:\/\/doi.org\/10.1039\/D0RA04949B","journal-title":"RSC Adv"},{"key":"790_CR66","doi-asserted-by":"publisher","first-page":"108661","DOI":"10.1016\/j.compbiolchem.2025.108661","volume":"120","author":"P Singh","year":"2026","unstructured":"Singh P, Akhtar A, Admane N, Grover A (2026) Adenine bolsters the monomeric conformations of the intrinsically disordered A53T mutant of \u03b1-Synuclein protein. Comput Biol Chem 120:108661. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108661","journal-title":"Comput Biol Chem"},{"key":"790_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108155","author":"P Singh","year":"2024","unstructured":"Singh P, Akhtar A, Admane N, Grover A (2024) The antiviral drug Ribavirin effectively modulates the amyloid transformation of \u03b1-Synuclein protein. Comput Biol Chem. https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108155","journal-title":"Comput Biol Chem"},{"key":"790_CR68","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"M Biancalana","year":"2010","unstructured":"Biancalana M, Koide S (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta Proteins Proteom 1804:1405\u20131412","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"790_CR69","unstructured":"OriginPro V (2016) OriginLab corporation. Northampton, MA, USA"},{"key":"790_CR70","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbapap.2008.10.016","volume":"1794","author":"AM Morris","year":"2009","unstructured":"Morris AM, Watzky MA, Finke RG (2009) Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim Biophys Acta Proteins Proteom 1794:375\u2013397","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"790_CR71","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.bbapap.2016.06.009","volume":"1864","author":"ES Lobbens","year":"2016","unstructured":"Lobbens ES, Breydo L, Skamris T et al (2016) Mechanistic study of the inhibitory activity of Geum urbanum extract against \u03b1-Synuclein fibrillation. Biochimica et Biophysica Acta (BBA) -. Proteins Proteom 1864:1160\u20131169. https:\/\/doi.org\/10.1016\/j.bbapap.2016.06.009","journal-title":"Proteins Proteom"},{"key":"790_CR72","doi-asserted-by":"publisher","first-page":"56a","DOI":"10.1016\/j.bpj.2021.11.2424","volume":"121","author":"N Admane","year":"2022","unstructured":"Admane N, Grover A (2022) A neurohypophyseal hormone analog modulates the amyloid aggregation of human prion protein. Biophys J 121:56a. https:\/\/doi.org\/10.1016\/j.bpj.2021.11.2424","journal-title":"Biophys J"},{"key":"790_CR73","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijbiomac.2022.11.049","volume":"223","author":"N Admane","year":"2022","unstructured":"Admane N, Srivastava A, Jamal S et al (2022) Molecular insights into the critical role of gallate moiety of green tea catechins in modulating prion fibrillation, cellular internalization, and neuronal toxicity. Int J Biol Macromol 223:755\u2013765. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.049","journal-title":"Int J Biol Macromol"},{"key":"790_CR74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/pro.4153","volume":"31","author":"AJ Miles","year":"2022","unstructured":"Miles AJ, Ramalli SG, Wallace BA (2022) ) <\u2009scp>DichroWeb, a website for calculating protein secondary structure from circular dichroism spectroscopic data. Protein Sci 31:37\u201346. https:\/\/doi.org\/10.1002\/pro.4153","journal-title":"Protein Sci"},{"key":"790_CR75","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s42003-023-05178-2","volume":"6","author":"AJ Miles","year":"2023","unstructured":"Miles AJ, Drew ED, Wallace BA (2023) DichroIDP: a method for analyses of intrinsically disordered proteins using circular dichroism spectroscopy. Commun Biol 6:823. https:\/\/doi.org\/10.1038\/s42003-023-05178-2","journal-title":"Commun Biol"},{"key":"790_CR76","doi-asserted-by":"publisher","unstructured":"Vilar M, Chou H-T, L\u00fchrs T et al (2008) The fold of \u03b1-synuclein fibrils. In: Proceedings of the national academy of sciences, pp 8637\u20138642. https:\/\/doi.org\/10.1073\/pnas.0712179105","DOI":"10.1073\/pnas.0712179105"},{"key":"790_CR77","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06592.x","volume":"113","author":"EA Waxman","year":"2010","unstructured":"Waxman EA, Giasson BI (2010) A novel, high-efficiency cellular model of fibrillar \u03b1\u2010synuclein inclusions and the examination of mutations that inhibit amyloid formation. J Neurochem 113:374\u2013388. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06592.x","journal-title":"J Neurochem"},{"key":"790_CR78","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle MD, Comellas G, Nieuwkoop AJ et al (2016) Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat Struct Mol Biol 23:409\u2013415. https:\/\/doi.org\/10.1038\/nsmb.3194","journal-title":"Nat Struct Mol Biol"},{"key":"790_CR79","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-021-02349-5","volume":"142","author":"M Hartlage-R\u00fcbsamen","year":"2021","unstructured":"Hartlage-R\u00fcbsamen M, Bluhm A, Moceri S et al (2021) A glutaminyl cyclase-catalyzed \u03b1-synuclein modification identified in human synucleinopathies. Acta Neuropathol 142:399\u2013421. https:\/\/doi.org\/10.1007\/s00401-021-02349-5","journal-title":"Acta Neuropathol"},{"key":"790_CR80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36402","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira R, Taylor NM, Mona D et al (2018) Cryo-EM structure of alpha-synuclein fibrils. Elife. https:\/\/doi.org\/10.7554\/eLife.36402","journal-title":"Elife"},{"key":"790_CR81","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1080\/07391102.2017.1388283","volume":"36","author":"KV Dileep","year":"2018","unstructured":"Dileep KV, Nithiyanandan K, Remya C (2018) Binding of acarbose, an anti-diabetic drug to lysozyme: a combined structural and thermodynamic study. J Biomol Struct Dyn 36:3354\u20133361. https:\/\/doi.org\/10.1080\/07391102.2017.1388283","journal-title":"J Biomol Struct Dyn"},{"key":"790_CR82","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbr.2015.01.052","volume":"284","author":"J-J Tong","year":"2015","unstructured":"Tong J-J, Chen G-H, Wang F et al (2015) Chronic acarbose treatment alleviates age-related behavioral and biochemical changes in SAMP8 mice. Behav Brain Res 284:138\u2013152. https:\/\/doi.org\/10.1016\/j.bbr.2015.01.052","journal-title":"Behav Brain Res"},{"key":"790_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01337-3","author":"MM Sonsalla","year":"2024","unstructured":"Sonsalla MM, Babygirija R, Johnson M et al (2024) Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer\u2019s disease. Geroscience. https:\/\/doi.org\/10.1007\/s11357-024-01337-3","journal-title":"Geroscience"},{"key":"790_CR84","doi-asserted-by":"crossref","unstructured":"Qi R, Wei G, Ma B, Nussinov R (2018) Replica exchange molecular dynamics: a practical application protocol with solutions to common problems and a peptide aggregation and self-assembly example. In: Peptide self-assembly: Methods in Molecular Biology. Humana Press Inc, New York, pp 101\u2013119","DOI":"10.1007\/978-1-4939-7811-3_5"},{"key":"790_CR85","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0009-2614(99)01123-9","volume":"314","author":"Y Sugita","year":"1999","unstructured":"Sugita Y, Okamoto Y (1999) Replica-exchange molecular dynamics method for protein folding. Chem Phys Lett 314:141\u2013151. https:\/\/doi.org\/10.1016\/S0009-2614(99)01123-9","journal-title":"Chem Phys Lett"},{"key":"790_CR86","doi-asserted-by":"publisher","DOI":"10.1063\/1.2404954","author":"X Periole","year":"2007","unstructured":"Periole X, Mark AE (2007) Convergence and sampling efficiency in replica exchange simulations of peptide folding in explicit solvent. J Chem Phys. https:\/\/doi.org\/10.1063\/1.2404954","journal-title":"J Chem Phys"},{"key":"790_CR87","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jmgm.2016.12.014","volume":"72","author":"M Han","year":"2017","unstructured":"Han M, Xu J, Ren Y (2017) Sampling conformational space of intrinsically disordered proteins in explicit solvent: Comparison between well-tempered ensemble approach and solute tempering method. J Mol Graph Model 72:136\u2013147. https:\/\/doi.org\/10.1016\/j.jmgm.2016.12.014","journal-title":"J Mol Graph Model"},{"key":"790_CR88","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/biom11101416","volume":"11","author":"X Gong","year":"2021","unstructured":"Gong X, Zhang Y, Chen J (2021) Advanced Sampling Methods for Multiscale Simulation of Disordered Proteins and Dynamic Interactions. Biomolecules 11:1416. https:\/\/doi.org\/10.3390\/biom11101416","journal-title":"Biomolecules"},{"key":"790_CR89","unstructured":"Koneru JK, Reid KM, Robustelli P (2025) Performing all-atom molecular dynamics simulations of intrinsically disordered proteins with replica exchange solute tempering. arXiv preprint arXiv:250501860"},{"key":"790_CR90","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature03680","volume":"435","author":"R Nelson","year":"2005","unstructured":"Nelson R, Sawaya MR, Balbirnie M et al (2005) Structure of the cross-\u03b2 spine of amyloid-like fibrils. Nature 435:773\u2013778. https:\/\/doi.org\/10.1038\/nature03680","journal-title":"Nature"},{"key":"790_CR91","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1039\/c2nr11508e","volume":"4","author":"A Yang","year":"2012","unstructured":"Yang A, Li X, Li D et al (2012) Observation of molecular inhibition and binding structures of amyloid peptides. Nanoscale 4:1895\u20131909","journal-title":"Nanoscale"},{"key":"790_CR92","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature10154","volume":"475","author":"SA Sievers","year":"2011","unstructured":"Sievers SA, Karanicolas J, Chang HW et al (2011) Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475:96\u2013100. https:\/\/doi.org\/10.1038\/nature10154","journal-title":"Nature"},{"key":"790_CR93","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ijbiomac.2020.03.064","volume":"156","author":"IM Stankovi\u0107","year":"2020","unstructured":"Stankovi\u0107 IM, Niu S, Hall MB, Zari\u0107 SD (2020) Role of aromatic amino acids in amyloid self-assembly. Int J Biol Macromol 156:949\u2013959","journal-title":"Int J Biol Macromol"},{"key":"790_CR94","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer DE, Bieschke J, Boeddrich A et al (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15:558\u2013566. https:\/\/doi.org\/10.1038\/nsmb.1437","journal-title":"Nat Struct Mol Biol"},{"key":"790_CR95","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SIA, Deas E et al (2012) Direct Observation of the Interconversion of Normal and Toxic Forms of \u03b1-Synuclein. Cell 149:1048\u20131059. https:\/\/doi.org\/10.1016\/j.cell.2012.03.037","journal-title":"Cell"},{"key":"790_CR96","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1039\/c4cp05563b","volume":"17","author":"P Arosio","year":"2015","unstructured":"Arosio P, Knowles TPJ, Linse S (2015) On the lag phase in amyloid fibril formation. Phys Chem Chem Phys 17:7606\u20137618. https:\/\/doi.org\/10.1039\/c4cp05563b","journal-title":"Phys Chem Chem Phys"},{"key":"790_CR97","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","volume":"115","author":"N Pandey","year":"2008","unstructured":"Pandey N, Strider J, Nolan WC et al (2008) Curcumin inhibits aggregation of \u03b1-synuclein. Acta Neuropathol 115:479\u2013489. https:\/\/doi.org\/10.1007\/s00401-007-0332-4","journal-title":"Acta Neuropathol"},{"key":"790_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1610586114","author":"M Perni","year":"2017","unstructured":"Perni M, Galvagnion C, Maltsev A et al (2017) A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.1610586114","journal-title":"Proc Natl Acad Sci"},{"key":"790_CR99","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejmech.2017.09.068","volume":"141","author":"H Zhang","year":"2017","unstructured":"Zhang H, Bai L, He J et al (2017) Recent advances in discovery and development of natural products as source for anti-Parkinson\u2019s disease lead compounds. Eur J Med Chem 141:257\u2013272. https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.068","journal-title":"Eur J Med Chem"},{"key":"790_CR100","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.bbapap.2014.04.013","volume":"1844","author":"Y Liu","year":"2014","unstructured":"Liu Y, Carver JA, Calabrese AN, Pukala TL (2014) Gallic acid interacts with \u03b1-synuclein to prevent the structural collapse necessary for its aggregation. Biochimica et Biophysica Acta (BBA) -. Proteins Proteom 1844:1481\u20131485. https:\/\/doi.org\/10.1016\/j.bbapap.2014.04.013","journal-title":"Proteins Proteom"},{"key":"790_CR101","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/cbic.201000604","volume":"12","author":"J Lu","year":"2011","unstructured":"Lu J, Ardah MT, Durairajan SSK et al (2011) Baicalein Inhibits Formation of \u03b1-Synuclein Oligomers within Living Cells and Prevents A\u03b2 Peptide Fibrillation and Oligomerisation. ChemBioChem 12:615\u2013624. https:\/\/doi.org\/10.1002\/cbic.201000604","journal-title":"ChemBioChem"},{"key":"790_CR102","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.3390\/ijms222413398","volume":"22","author":"MT Ardah","year":"2021","unstructured":"Ardah MT, Eid N, Kitada T, Haque ME (2021) Ellagic Acid Prevents \u03b1-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated \u03b1-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy. Int J Mol Sci 22:13398. https:\/\/doi.org\/10.3390\/ijms222413398","journal-title":"Int J Mol Sci"},{"key":"790_CR103","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1021\/acschemneuro.1c00001","volume":"12","author":"S Kumar","year":"2021","unstructured":"Kumar S, Kumar R, Kumari M et al (2021) Ellagic Acid Inhibits \u03b1-Synuclein Aggregation at Multiple Stages and Reduces Its Cytotoxicity. ACS Chem Neurosci 12:1919\u20131930. https:\/\/doi.org\/10.1021\/acschemneuro.1c00001","journal-title":"ACS Chem Neurosci"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00790-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:38:24Z","timestamp":1774496304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00790-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00790-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"85"}}